INR 83.64
(5.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 22.4 Billion INR | -0.0% |
2022 | 22.4 Billion INR | -0.0% |
2021 | 22.4 Billion INR | -0.03% |
2020 | 22.41 Billion INR | 0.03% |
2019 | 22.4 Billion INR | -1.99% |
2018 | 22.85 Billion INR | 5.45% |
2017 | 21.67 Billion INR | 240.11% |
2016 | 6.37 Billion INR | -0.08% |
2015 | 6.37 Billion INR | -4.88% |
2014 | 6.7 Billion INR | -1.31% |
2013 | 6.79 Billion INR | -60.52% |
2012 | 17.21 Billion INR | 77.57% |
2011 | 9.69 Billion INR | 45.85% |
2010 | 6.64 Billion INR | 173.83% |
2009 | 2.42 Billion INR | 392.25% |
2008 | 493.06 Million INR | 2.31% |
2007 | 481.92 Million INR | -22.78% |
2006 | 624.12 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 3.44 Billion INR | -84.64% |
2023 Q2 | 22.39 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 22.4 Billion INR | -0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 22.4 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 22.41 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q4 | 22.4 Billion INR | 0.0% |
2022 FY | 22.4 Billion INR | -0.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 22.4 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 22.4 Billion INR | 0.0% |
2021 FY | 22.4 Billion INR | -0.03% |
2020 Q2 | 22.41 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 22.41 Billion INR | 0.0% |
2020 FY | 22.41 Billion INR | 0.03% |
2020 Q1 | - INR | -100.0% |
2019 FY | 22.4 Billion INR | -1.99% |
2019 Q4 | 22.4 Billion INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q2 | 21.65 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 FY | 22.85 Billion INR | 5.45% |
2018 Q4 | 22.85 Billion INR | 0.0% |
2017 FY | 21.67 Billion INR | 240.11% |
2016 FY | 6.37 Billion INR | -0.08% |
2015 Q1 | - INR | -100.0% |
2015 Q3 | - INR | -100.0% |
2015 Q4 | 6.37 Billion INR | 0.0% |
2015 FY | 6.37 Billion INR | -4.88% |
2015 Q2 | 6.32 Billion INR | 0.0% |
2014 Q2 | 6.74 Billion INR | 0.0% |
2014 FY | 6.7 Billion INR | -1.31% |
2014 Q4 | 6.7 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2013 Q2 | 14.95 Billion INR | 0.0% |
2013 FY | 6.79 Billion INR | -60.52% |
2013 Q4 | 6.79 Billion INR | 0.0% |
2012 Q4 | 17.21 Billion INR | 0.0% |
2012 FY | 17.21 Billion INR | 77.57% |
2012 Q2 | 13.21 Billion INR | 0.0% |
2011 FY | 9.69 Billion INR | 45.85% |
2011 Q2 | 11.29 Billion INR | 0.0% |
2011 Q4 | 9.69 Billion INR | 0.0% |
2010 Q4 | 6.64 Billion INR | 0.0% |
2010 FY | 6.64 Billion INR | 173.83% |
2009 FY | 2.42 Billion INR | 392.25% |
2008 FY | 493.06 Million INR | 2.31% |
2007 FY | 481.92 Million INR | -22.78% |
2006 FY | 624.12 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ador Multiproducts Limited | 28.52 Million INR | -78429.645% |
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -1936.997% |
Bajaj Consumer Care Limited | 1.53 Billion INR | -1364.234% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | -69.441% |
Cupid Limited | 186.52 Million INR | -11910.624% |
Dabur India Limited | 48.19 Billion INR | 53.517% |
Emami Limited | 8.21 Billion INR | -172.545% |
Gillette India Limited | 8.59 Billion INR | -160.657% |
Godrej Consumer Products Limited | 58.97 Billion INR | 62.012% |
Hindustan Unilever Limited | 270.76 Billion INR | 91.726% |
Hipolin Limited | 48.57 Million INR | -46022.202% |
Honasa Consumer Limited | 5.36 Billion INR | -317.363% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | -8145.286% |
Jyothy Labs Limited | 5.9 Billion INR | -279.248% |
Kaya Limited | 5.22 Billion INR | -328.979% |
Marico Limited | 32.52 Billion INR | 31.11% |
PAOS INDUSTRIES LIMITED | 163.96 Million INR | -13562.91% |
Paramount Cosmetics (India) Limited | 205.72 Million INR | -10789.749% |
Pee Cee Cosma Sope Limited | 80.17 Million INR | -27841.153% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | -106.726% |